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Abstract
Background: Slums or informal settlements characterize most large cities in LMIC. Previous evidence suggests
pharmacies may be the most frequently used source of primary care in LMICs but that pharmacy services are of
variable quality. However, evidence on pharmacy use and availability is very limited for slum populations.
Methods: We conducted household, individual, and healthcare provider surveys and qualitative observations on
pharmacies and pharmacy use in seven slum sites in four countries (Nigeria, Kenya, Pakistan, and Bangladesh). All
pharmacies and up to 1200 households in each site were sampled. Adults and children were surveyed about their
use of healthcare services and pharmacies were observed and their services, equipment, and stock documented.
Results: We completed 7692 household and 7451 individual adults, 2633 individual child surveys, and 157 surveys
of pharmacies located within the seven sites. Visit rates to pharmacies and drug sellers varied from 0.1 (Nigeria) to
3.0 (Bangladesh) visits per person-year, almost all of which were for new conditions. We found highly variable
conditions in what constituted a “pharmacy” across the sites and most pharmacies did not employ a qualified
pharmacist. Analgesics and antibiotics were widely available but other categories of medications, particularly those
for chronic illness were often not available anywhere. The majority of pharmacies lacked basic equipment such as a
thermometer and weighing scales.
Conclusions: Pharmacies are locally and widely available to residents of slums. However, the conditions of the
facilities and availability of medicines were poor and prices relatively high. Pharmacies may represent a large
untapped resource to improving access to primary care for the urban poor.
Keywords: Healthcare access, Pharmacies, LMICs, Slums, Welfare
Introduction
Informal settlements and slums are home to a large and
growing proportion of the world’s population: approxi-
mately one billion people are estimated to live in these
neighborhoods, [1] almost exclusively in low and middle
income countries (LMICs) [2, 3]. While various defini-
tions of a slum exist, all invariably are based on exposure
to hazards to human health and poor living standards
either in the household or local environment [4]. Slum
residents are also likely to face significant barriers when
accessing healthcare [2, 3]. There is thus a priority to
improve access to high quality health services for people
living in slums, particularly in the context of achieving
Universal Health Care (UHC).
Strengthening primary care has been described as the
most “inclusive, effective, and efficient approach” to im-
proving population health and wellbeing as part of
achieving UHC globally [5]. “Primary care” is broadly de-
fined as the first point of contact a patient makes with a
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health system and can include outpatient consultations
with doctors and nurses, specialist providers, traditional
and faith-based practitioners, and pharmacies – the sub-
ject of this article. Pharmacies provide medicines pre-
scribed by doctors and nurses but they are also
frequently the first and only place of contact when a
health need arises and as such are often recognized as
performing a wider public health role [6–8]. A well-cited
example is the use of pharmacies to purchase anti-
tussives by individuals presenting with chronic cough;
pharmacies can play a key role in referring patients with
suspected TB [8]. In Bangladesh, previous evidence has
shown that slum dwellers make extensive, and often ex-
clusive, use of pharmacies relative to other providers for
a range of conditions [9].
A systematic review of pharmacy and drug store per-
formance in LMICs in Asia found evidence of wide-
spread inadequacies in services including inappropriate
and illegal prescribing and dispensing of drugs, lack of
referral, and a lack of information provision to cus-
tomers [10] Similar results were also found in Sub-
Saharan Africa [11]. These characteristics are often fur-
ther combined with high prices, which are unaffordable
for many [12–14].
Given the potentially frequent use of pharmacies and
risk of low-quality care, they are therefore an obvious
target to improve healthcare for the urban poor. Educa-
tional and quality improvement interventions have been
shown to improve pharmacy practice [15]. However, the
evidence is fairly limited on the availability and use of
pharmacies and drug stores, the variability in what con-
stitutes a pharmacy in different urban settings, and the
availability of equipment, staff, and medication in those
facilities. The role that pharmacies can play in improving
access to high-quality healthcare, and how they should
be engaged with from a policy perspective [16–20],
strongly depends on their capacity to provide services
and their available equipment and expertise. We there-
fore examined the availability and use of pharmacies
among the urban poor, archetypically represented by
those living in informal settlements. In each of seven
slum sites across Nigeria, Kenya, Pakistan, and
Bangladesh, we observed the distribution of pharmacies,
the type of business and medicines stocked by each
pharmacy, and we estimated use rates among the local
population. We hypothesized that we would find rela-
tively frequent use of pharmacies for both pre-existing
and new conditions, and that the available services
would be poor quality.
Methods
Setting
The aim of this study was to examine pharmacies avail-
able to urban slum dwellers from both the supply and
demand perspectives. The data analyzed for this article
were collected as part of a larger programme of work
examining health and healthcare in informal settlements,
the methods of which are described in detail elsewhere
[21]. The surveys investigated use of a wide range of
providers including outpatient doctor and nurse care,
specialist care, inpatient care, and traditional and faith-
based practice. Analyses of other types of care are re-
ported elsewhere. We describe the specifics of the
methods here relevant to the reported results. Legally
there are distinctions between “drug vendors”, “patent
medicine sellers”, pharmacies, and other types of facil-
ities in each of our countries, although all provide phar-
macy services. In the absence of an operationalizable set
of definitions, we categorized any facility meeting the
definition “A facility used for the compounding, dispens-
ing of medicinal preparations, and/or other associated
professional and administrative services” as a pharmacy,
and investigated the heterogeneity of products and ser-
vices available within this category.
Study population
The study was conducted in seven informal settlements
in four countries. The sites, which we label anonym-
ously, were in Nigeria (NG1, NG2, NG3), Kenya (KE1,
KE2), Pakistan (PK1), and Bangladesh (BD1). The sites
were chosen on the bases that they: (1) fulfilled the UN
definition of a ‘slum’ and (2) were named, geographically
distinguishable, neighborhoods within city boundaries.
Each site occupied a distinct geographical area that de-
fined the boundaries in which we surveyed all pharmacy
facilities and sampled households and individuals, as de-
scribed below.
Study design and procedures
Three datasets were collected comprising quantitative
supply and demand side observations, and qualitative
observations of the pharmacy facilities.
Health care facilities survey
All structures in each site were first mapped using Very
High Resolution satellite imagery, and then “ground-
truthed” through participatory mapping and corrected as
required. All households in each structure were identi-
fied, which formed the sampling frame for the household
survey described below. Non-residential structures were
identified as such and we determined if they housed
health care facilities. Field workers later returned to
complete a comprehensive facilities survey in each
location. We classified and defined facilities according to
the schema in Table S2 (Supplementary Information)
adapted from the American Medical Association’s tax-
onomy, local knowledge, and other sources [22]. A
health facility could meet multiple definitions depending
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on its services and data were collected relevant to its
classification(s).
Health care facility surveys aimed to capture the avail-
able services, human resources, products, and tests and
diagnostic facilities available at each facility. Questions
were facility type dependent. For pharmacies, the avail-
ability of medicines on the WHO list of essential medi-
cines in the specific formulations was assessed [23], as
well as basic medical equipment, such as weighing scales
and latex gloves (detailed below). The availability of
qualified medical personnel was assessed at all facilities;
different grades of qualification were country specific.
For pharmacies, we collected data specifically on quali-
fied pharmacists and “pharmacy technicians” and related
support staff. We also identified opening hours and costs
where possible. Table 1 summarises the criteria used to
characterize the facilities. We aimed for our list of cri-
teria to be comprehensive and cover all the possibilities
that a facility might reasonably have.
Qualitative observations of health care facilities
Qualitative observation was undertaken at each facility
surveyed, by two or three fieldworkers trained in the
ethics and techniques of the method. An observation
guide directed them to observe place, people, and activ-
ities and to note their overall impressions. Fieldnotes
were taken on the health facility environment, structure,
services advertised, apparent stock levels and activities at
the time of observation. Observations were recorded in
situ as handwritten notes that were expanded, tran-
scribed, translated and digitized daily. These were sum-
marized thematically and compared across sites.
Household and individual surveys
From the sampling frame of households described above,
we used an inhibitory sampling design with close pairs
to generate a spatially-regular and well-dispersed sample
of 1200 households for each study site [24], assuming a
response rate of 80%. Within each household, all resi-
dents were identified and an adult over 18 and a child
under 12 were selected at random for the individual sur-
veys. Adult women were oversampled compared to men
at a ratio of 2:1 as we expected greater healthcare use
among women. Up to three attempts were made to
complete each survey should the participant not be
available at the initial attempt.
Three instruments were used in the household-based
surveys: (i) a household level survey containing a house-
hold roster, demographic, and socioeconomic questions
including those used to construct the Demographic and
Health Survey (DHS) wealth index [25]; (ii) an individual
adult survey enquiring about health care need, access,
and use, and health and well-being; and (iii) a child
(under 12 years of age) survey asking a caregiver about
health care needs, access, and use. Questions were
adapted from similar studies to facilitate comparability
[26]. The adult and child surveys both asked the respon-
dents to provide details of the last time they used health-
care (if they had done so in the previous 12 months),
including facility type (pharmacy, clinic, hospital, etc.),
who they saw (doctor, nurse, pharmacist, etc.), the rea-
son for the visit, the cost and time taken for the visit,
and questions regarding their satisfaction with the care
provided.
The data were collected on Android tablet devices
using Open Data Kit software [27]. Survey instruments
were translated using an iterative process involving for-
ward and independent backward translations until a
Table 1 Evaluation of available pharmacy products and services
We summarized the available equipment and services at each pharmacy
according to the following criteria. Within each category the maximum
score was one.
Essential medication
Within each category we totaled the number of the medications
available (1 point if available, 0.5 points if available in a different dose or
formulation) and divided by the number of drugs in the category.
Antibiotics (4) Ciprofloxacin capsules (500 mg), co-trimoxazole suspen-
sion (8 + 40mg/ml), amoxicillin capsules or tablets (500mg), ceftriaxone
injection (1 g/vial).
Analgesics (2) Diclofenac capsules (150 mg), paracetamol suspension
(125 mg/ml)
Non-antibiotic medications for communicable diseases (6)
Fluconazole capsules or tablets (150mg), albendazole (400mg) or
mebendazole (100mg or 500 mg) chewable tabs, oral rehydration salts
(ORS) sachets, artemisinin combination therapy, isoniazid tablets (100 to
300mg), fansidar (SP, sulfadoxine + pyrimethamine) tablets (500 mg +
25mg)
Medications for chronic illnesses (6) Salbutamol inhaler (0.1 mg/dose),
glibencamide capsules or tablets (50 mg), atenolol capsules or tablets
(50 mg), captopril (25 mg) or enalapril (2.5 mg) capsules or tablets,
simvastatin capsules or tablets (20 mg), Efavirenz + lamivudine +
tenofovir tablet (TDF + 3TC + EFV) (or relevant national standard for HIV)
Medications for sexual health, family planning, and pregnancy (4)
Oxytocin injection (10 IU in 1 ml ampule), combined oral contraceptive
pills, medroxyprogesterone (25 mg) injectable contraceptive, male
condoms.
Other medications (3) Amitriptyline capsules or tablets (25 mg),
omeprazole capsules or tablets (20 mg), vitamin A capsules (200,000 IU).
Medical equipment
Within each category we totaled the number of the items available and
divided by the number of items in the category.
Drug preparation and storage (4) Autoclave for sterilization, infusion
kits for intravenous solution, refrigerator, latex gloves.
Basic diagnostic equipment (7) Microscope, slides,
sphygmomanometer, stethoscope, adult weighing scale, weighing
equipment for under fives, thermometer.
Advanced equipment (3) X-ray machine, oxygen system/cylinders,
cytoflowmeter.
Pharmacy staff
For each category the pharmacy scored 1 for one or more full time staff
member and 0.5 for one or more part time staff member.
Qualified pharmacist (with or without degree certificate)
Pharmacy technician (staff with lower-level qualifications)
Opening hours
The proportion of the week the pharmacy is open (out of 14, with each
day divided into AM/PM).
Overall summary (Fig. 2)
An overall summary score summing all items in the medication,
equipment, and staff categories was also calculated.
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version was agreed and were then delivered in the local
language.
Quality control
The data were quality controlled in the field, by field su-
pervisors, using spot checks and direct observation. Data
submitted to the server was inspected and cleaned and
any errors or mismatching identifiers were identified
and sent back to the field for verification. Initial observa-
tions were reviewed with fieldworkers and feedback
given to optimize observations.
Outcomes and analysis
Pharmacy summaries and available services
Summaries of data from the healthcare facilities surveys,
including number of pharmacies and availability of
medication equipment and staff, are presented as means,
totals, or proportions without inferential statistics as
they cover the whole population of facilities in the sur-
vey area. We informally summarise the products and
services available at pharmacies in each area as described
in Table 1. The list was not intended to be prescriptive
or ideal and it includes items few, if any, pharmacies
would reasonably have. However, it captures a broad
view of the available services, equipment medicines, and
staff available through local pharmacy outlets.
Pharmacy use and access
For analyses of data from the household and individual
surveys, survey weights were calculated by bootstrapping
the sampling procedure with 10,000 iterations, and aver-
ages (means, medians, or quantiles, etc.) are population
weighted where they are reported.
We compared age-standardised visit rates to phar-
macies with visits to other types of provider. This
was accomplished by taking the overall outpatient
healthcare visit rate, multiplying by the reported pro-
portion of visits to the relevant provider with each
age category, and then weighting using the INDEPTH
LMIC standardized population [28]. To obtain 95%
confidence intervals for these rates we bootstrapped
this procedure 1000 times. We subdivided visits into
those reported for “new conditions” and those for
chronic or “existing conditions”. We also summarized
the reasons for seeking care.
Observation of pharmacies
Qualitative observations were collated, read and reread
by the team. Through comparison of data within and be-
tween sites we generated descriptions of different facility
types.
Results
Pharmacies, products, and services available
Overall, we identified 226 pharmacies across the seven
slum sites (Table 2). Pharmacies were identified in all
seven sites and included legally designated full-service
pharmacies and several other classifications including
patent medicine vendors (Nigeria), community and pub-
lic health pharmacies (Kenya), medical stores (Pakistan),
and medical shops (Bangladesh). Site NG1 had the most
pharmacies per 1000 residents in the slum precinct and
pharmacy technicians per capita, although all were lower
designated “patent medicine vendors”; BD1 had the most
qualified pharmacists per capita. Figure 1 summarises
the available products, equipment, staff, and services
available in the pharmacies in each slum site, and Fig. 2
shows a map of selected facilities that gave permission
to show their location.
The proportion of pharmacies stocking each of the es-
sential medicines is reported in Table S2 (Supplemen-
tary). Almost all essential medicines could be found
within each slum site with the exception of those for
chronic illness, including salbutamol (asthma), glibenca-
mide (diabetes mellitus type 2), atenolol and captopril
(hypertension), which were not available in the Nigerian
sites and only partially available in the other sites. Oral
contraceptives and condoms were available in all sites,
but injectable contraceptives and pregnancy related
medication were only available in KE2, PK2, and BD1,
and only from a minority of pharmacies. Analgesia and
antibiotics were widely available from most outlets in all
countries.
Most pharmacies lacked basic equipment, including
thermometers, weighing scales, and latex gloves (Table
S3, Supplementary Information). Except for pharmacies
in sites KE2 and BD1, the majority of pharmacies also
lacked basic diagnostic equipment, such as blood pres-
sure machine, weighing scales, and thermometer. Only
site KE2 had pharmacies that scored 0.5 or better in
every category (3 pharmacies of 68; see Table 1), and
these were all attached to clinics.
Qualitative pharmacy observations
Our definition of ‘pharmacy’ included a broad range
of businesses and providers, from field-apprenticed
drug vendors working in makeshift structures or
stools to qualified pharmacists working in well-lit,
ventilated and clean premises. Table 3 summarises
our field observations.
Pharmacy use
Summary statistics of the surveyed individuals are re-
ported in Supplementary Information. Figure 3 shows
the visit rates to pharmacies alongside visit rates to other
providers. Sites BD1 and KE2 were the only sites where
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visits to pharmacies were more frequent than visits to
doctors or nurses. For example, in BD1 adults made on
average three visits a year for new conditions compared
to under 2 to doctors and nurses. Pharmacy visit rates in
the other sites ranged from 0.1 (PK1) to 0.8 (KE1) visits
per person-year. PK1 had a much lower visit rate to
pharmacies than any other site as most respondents
accessed medication and related services directly from a
doctor in a clinic setting. Almost all visits were for new
conditions. Visits for children were made at a compar-
able rate to adults. Figure 4 reports the proportions of
reported outpatient visits to a pharmacy for different
reasons for needing care. Acute conditions and pain
were generally the categories most likely to result in a
visit to a pharmacy. “High-risk” presentations, including
chest pain, difficulty breathing, and stroke or sudden
paralysis, accounted for between 1 and 5% of pharmacy
visits. In NG1 and PK1 no visits for these conditions
were reported to the pharmacy, however in the other
sites anywhere from 10 to 40% of visits for these reasons
were to a pharmacy.
Cost and time to use pharmacy services
Table 4 reports the time and cost of a visit to a phar-
macy in each site. The majority of all visits in all sites re-
quired less than 10min of travel and less than 5 min of
waiting. The highest spend per visit was highest in
Nigeria where the median cost in the three sites ranged
from Int$8 to 13. The lowest spend was in Kenya where
the median cost was Int$ 3 in both sites.
Discussion
We find that slum precincts are replete with drug sellers
and pharmacists. As can be seen from Figs. 1 and 2,
Table 2 Summary of pharmacies and pharmacy staff in each study site
Nigeria Kenya Pakistan Bangladesh
NG1 NG2 NG3 KE1 KE2 PK1 BD1
Population 5800 5500 8100 24,000 45,000 33,500 60,000
Pharmacies total 22 15 6 14 68 9 92
Pharmacies per 1000 3.8 2.7 0.7 0.6 1.5 0.3 1.5
Pharmacistsa per 1000 0.5 0.0 0.0 0.0 0.3 0.1 0.6
Pharmacy techniciansa per 1000 2.9 2.7 0.6 0.2 0.7 0.2 0.0
aEither full-time or part-time
Fig. 1 Graphical summary of the available products and services available in the pharmacies located within each slum area. Within each plot
each pharmacy is represented by a separate row, and each column is a category as described in Table 1, with yellow indicating complete
availability of all items in the category and dark blue none of the items available
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Fig. 2 Locations of a selection of publicly identified pharmacies in each study site. Each location is coloured according to its overall summary
score (see Table 1)
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there is a high density of pharmacies in slums; over a
half of people across all seven slums live within a ten-
minute walk of a place selling medicines. That said, in
four of our sites there was no qualified pharmacist work-
ing in the slum and in the remaining three sites the ratio
of pharmacists to pharmacies varied from one in five to
one in two. The availability of medicines from the WHO
list of essential medicines was also very variable across
vendors and in Nigeria and Kenya we found many of the
essential medicines and basic equipment were not avail-
able, although we recognize our list of medication and
equipment was not completely comprehensive. Many of
the facilities were not legally permitted to sell certain
medications, for example, patent medicine vendors in
Table 3 Qualitative observations of pharmacy characteristics
Characteristic Summary
Premises Premises ranged from small street stalls (e.g. 3ftx4ft) to larger independent medical stores (e.g. 10ftx12ft) and, in Kenya, Nigeria
and Pakistan, dispensaries operating within clinics, health centres, and a sub-county hospital (KE1). Most were located along busy
roads, within markets or near transport hubs and were often in close proximity to each other.
Goods and
services
Depending on pharmacy size and scope, medical goods ranged from a few boxes of over-the-counter-drugs to shelves ‘loaded
with tablets and syrups.’ Some also stocked herbal remedies. Most sold non-medical goods (e.g. soft drinks, soaps, sweets) and al-
most all offered mobile SIM and recharge services. In Kenya, Nigeria and Bangladesh, few displayed contact details, opening hours
and authentication certificates. In Kenya and Bangladesh, some pharmacies were adjoined by a small doctor’s consulting chamber
(e.g. 5ftx7ft). Drugs were often dispensed in small quantities (e.g. two tablets) in unlabeled containers, although some providers
wrote or gave verbal directions to customers.
Privacy Privacy was limited by space in all sites and customers often had to discuss and purchase items while standing on the street or a
pavement step.
Cleanliness In all sites, most facilities were located near to open drainage and ‘a lot of garbage’. Many sought to improve customer
accessibility with wooden planks and elevated entrances. Inside, some stores were very dusty or ‘grimey’, others clean, well-lit and
cooled by electric fans.
Opening hours In all sites, most facilities stayed open late at night, 6–7 days per week, with owners on call after hours. For many, this was largely
to accommodate ‘people who return late from work and need to get drugs especially pain relievers, most even call to book drugs
and plead [for me to wait for them]’
Staff In all sites, the owner/main provider was often referred to as ‘doctor’. Most drug vendors had undergone ‘in field’ training as
apprentices and many in Nigeria and Bangladesh now employed apprentices themselves. A few mentioned medical backgrounds
as nurses (NG, KE) or clinical medical officers (KE). Some were working elsewhere in ‘day jobs’ (in other health facilities or different
industries outside of the site). During quiet times (e.g. mornings), young apprentices, family members or neighbours might be left
to attend to occasional customers but at busier times and in larger facilities, teams of 3–6 assistants might work together to keep
queues moving. In all sites, most providers were seen to be courteous and professional. Often a customer would first consult
about their symptoms (no fee charged). Providers would then prescribe and sell treatment; or occasionally refer to a doctor/clinic.
Prices Most transactions were in cash. In Nigeria, drug prices and quantities were negotiable, depending on ‘the severity of the case and
the bargaining power’ of the customer. In Nigeria and Kenya, drugs were sold at government-subsidized rates in the primary
healthcare centres. At the community primary healthcare centre in NG1, anti-malaria drugs were free and staff said they were al-
ways available (NG1). In Bangladesh, one pharmacy had a reimbursement arrangement to supply medicine at no cost to patients
with prescriptions from a donor-funded clinic in the site.
Fig. 3 Pharmacy, doctor and nurse, and other consultations rates per person-year for adults and children (under 12) for both new and existing
conditions with 95% confidence intervals
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Nigeria were highly restricted in what drugs they could
sell, while others were allowed to sell the drugs but did
not have them in stock. These findings within slums are
consistent with those found more generally in LMIC
where poorly stocked outlets with poor service quality
are widespread [10].
The high number of pharmacies in slums will come as
no surprise to people familiar with informal settlements;
they are a highly visible feature of the slum environment.
But our study provides scientific confirmation that medi-
cine outlets are plentiful. Medicines though are an out
of pocket expense for people who live in slums [2]. Sub-
sidized or third part payment is almost absent, except
for in Kenya. And even when third party payments are
available they tend to cover consultations not drug costs.
The inference is that there must be sufficient private de-
mand for medication in slums to support the high dens-
ity of medicine sellers observed in this study.
We have described the typical costs spent on medi-
cines above. In a companion study we show that medi-
cines make up the largest proportion of outpatient costs
exceeding those of consultations, even those that take
place in the public sector. Given these costs, the lack of
qualified staff, lack of privacy and cleanliness in many
premises, and often poor availability of essential medica-
tion and equipment, we would concur that the plentiful
pharmacy outlets are likely to provide a poor-quality ser-
vice at high monetary cost [10, 11]. Our survey enquired
after the last healthcare visit an individual made, so none
of the pharmacy visits described here include a subse-
quent referral, even for potentially high-risk symptoms.
Such a scenario leads to the hypothesis that medicine
sellers are insufficiently knowledgeable. However, educa-
tion is at best a partial solution according to a recent
systematic review [15]. The review concluded that the
interests of client and provider were poorly aligned lead-
ing to ‘market failure’. There is implicit recognition of
this issue in countries rich and poor, including the four
countries in our study, since medicine sales are regu-
lated. The problem would appear to be one of enforce-
ment which in turn is a function of money and political
will. It is possible this is a reflection of the legal status of
slums, however other evidence suggests the problems
are not limited to these areas [10, 15]. Managing situa-
tions such as this is a perennial issue in development
economics and it is to these methods that we believe we
should turn with respect to improving the quality of
pharmacy practice by theoretically sound and propor-
tionate ways to gradually improve practice and services
and ‘crowd out’ poor performance while rewarding good
providers [29].
In developing a policy to improve pharmacy practice,
it will be important to take into account one particular
finding from our study; namely that there is a pressing
demand for direct access to pharmacies in our sample –
or at least relatively low cost, proximal, and rapid health
Fig. 4 Proportion of reported visits by reason for seeking care that were to a pharmacy with 95% confidence intervals. “High risk presentation”
includes chest pain, difficulty breathing, and stroke or sudden paralysis
Table 4 Median [IQR] travel and waiting times and spend per visit to pharmacies by study site
Nigeria Kenya Pakistan Bangladesh
NG1 NG2 NG3 KE1 KE2 PK1 BD1
Spend per visit (Int$) 8 [3, 17] 8 [2, 13] 13 [5, 23] 3 [1, 10] 3 [1, 6] 5 [3, 9] 6 [2, 11]
Travel time (mins) 5 [5, 11] 5 [5, 10] 10 [5, 15] 10 [5, 20] 10 [5, 20] 5 [5, 10] 5 [4, 10]
Wait time (mins) 2 [0, 5] 2 [1, 5] 2 [1, 5] 1 [0, 5] 2 [0, 5] 4 [0, 5] 5 [3, 10]
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care provision. This has two implications. First, pharma-
cies are a vast untapped resource for health prevention
strategies and appropriate referral, with a potentially
large public health role [7, 8]. This potential should be
explored in the development and evaluation of policy.
Second, providing public funding for access to standard
health services is unlikely to extinguish demand to pur-
chase some medicines directly since it has not done so
in High Income Countries. The need to improve and
capitalize on the medicine selling/pharmacy industry will
thus remain an important policy objective notwithstand-
ing extension of public funding and subsidies as well as
improved regulation.
In conclusion, we show that the development of a vi-
able market for medicines in urban areas extends into
slums themselves but that there are grounds for thinking
that this market does not operate effectively and needs
carefully designed and enforceable regulation in addition
to any education to fill knowledge gaps. Opinions re-
garding the role of community pharmacists has seen a
shift in recent years from solely retailing products to tak-
ing on a substantial public health role comprising pro-
motion, prevention, and disease management [8, 29].
The proximity of pharmacies to slums and often poor
access to other types of care for slum residents face sug-
gest that the shift to providing essential public health
services should be explored in slum areas.
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